Professor Ulf Ziemann and Professor Mathias Jucker are among the world's most cited scientists again this year, according to a recent analysis by Clarivate Analytics. Of the world’s population of…
At the HIH, as part of the Johannes Dichgans scholarship program, doctoral scholarships for students of human medicine will again be offered for the summer semester 2023.
The goal of the Helfrich lab is to unravel the neural network mechanisms supporting higher cognitive functions and their disturbances underlying neuropsychiatric disorders. We study the functional…
The HIH will collaborate with the Paris Brain Institute (ICM) in Paris with a joint project to investigate biomarker changes in neurodegenerative diseases. Prof. Dr. Mathias Jucker (HIH), Dr.…
The "Verein der Freunde der Gemeinnützigen Hertie-Stiftung" accepted the invitation to Tübingen and visited the HIH on October 14, 2022.
After a welcome from the Chairman of the Board,…
Our group is interested in developing new treatment options for patients affected by drug resistant seizures and associated encephalopathic syndromes.
About 30-50 % of all epilepsies are of…
Our research group uses transgenic mouse models to investigate the molecular mechanisms of disease-associated variants in genes encoding neuronal ion channels. These so-called channelopathies…
Ruschil C, Kemmerer CL, Beller L, Gabernet G, Kowarik MC. Next Generation Sequencing of Cerebrospinal Fluid B Cell Repertoires in Multiple Sclerosis and Other Neuro-Inflammatory Diseases-A…
